Rash Decisions: Diagnosing and Treating Skin Lesions
- Speaker:
- Damien Fisher, PharmD, AE-C
- Duration:
- 2 Hours 03 Minutes
- Format:
- Audio and Video
- Copyright:
-
May 16, 2025
- Product Code:
- POS078945
- Media Type:
- Digital Seminar
Description
Atopic dermatitis and psoriasis can be difficult to treat, new guidelines include biologics as being the standard of therapy due to their efficacy. Other therapies are gaining traction as adjunctive therapy for these dermatological conditions. Treatment guidelines for conditions like atopic dermatitis and psoriasis include a range of options. For atopic dermatitis, treatments involve topicals such as corticosteroids, calcineurin inhibitors, VTAMA, and Opzelura, as well as biologics like Dupixent, Adbry, and Ebglyss, and Jak inhibitors such as Cinbinqo and Rinvoq. Psoriasis is treated with TNF-alpha inhibitors, IL-17 inhibitors, and IL-23 inhibitors. Light therapy is also recognized as an important adjunctive treatment for these conditions.
In addition, over the counter (OTC) medications are commonly used for dermatological issues, and their appropriate application and duration are key in deciding when to seek advanced care. Nonpharmacological treatments such as wound care and skincare routines, including moisturizers, are also significant. Ongoing research is focused on new therapies, with particular attention to biologics for psoriasis and atopic dermatitis. Barriers to treatment include financial concerns, cost-effectiveness, prescription assistance programs, insurance, and myths about biologics. Challenges such as compliance, needle phobia, and uncertainty about treatment efficacy also need consideration, along with the importance of lab monitoring and follow-up care.
Credit
Handouts/Brochure
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Rash Decisions Diagnosing and Treating Skin Lesions (4.8 MB) | 61 Pages | Available after Purchase |
Speaker
Damien Fisher, PharmD, AE-C Related seminars and products
University of Texas Medical Branch
Damien Fisher, PharmD, AE-C, graduated from Florida A&M University College of Pharmacy with Doctor of Pharmacy degree in 2004. He prolonged his studies and completed an American Society Health System Pharmacists (ASHP) accredited residency with an emphasis on community and ambulatory care at the University of Tennessee. He became intrigued in academia, during his career has held three Clinical Assistant Professor positions at Hampton University School of Pharmacy and University of Houston College of Pharmacy, as well as South University School of Pharmacy. His passion in the ambulatory care world is within the areas of pulmonary and dermatology. He is currently ce4rtified as an asthma educator and is heavily involved with the American Lung Association (ALA) as a national presenter. He extended his oratory skills to other organizations such as Georgia Pharmacist Association, National Pharmacist Association, and the Better Breathers Club. He serves as a board member to the National Association Certified Asthma Educator Board and as clinical consultant to the National Board of Respiratory Care (NBRC) advocating for asthma educators’ opportunities. Damien is currently working at University of Texas Medical (UTMB) as an outpatient pharmacy clinical practice specialist within the specialty of pulmonology, dermatology, and allergy. As a patient advocate in this position, Damien ensures his patients achieve healthy outcomes from biologic or nonbiologic medications.
Speaker Disclosures:
Financial: Dr. Damien Fisher has employment relationships with the University of Texas Medical Branch, Texas Southern University, CVS Pharmacy, University of Houston College of Pharmacy, and the American Lung Association Speaking Bureau. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Damien Fisher is a member of the National Pharmacist Association. He is a medical advisory board member for the American Lung Association.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Determine the current pharmacological treatments for plaque psoriasis and atopic dermatitis, including topical therapies, systemic treatments, and biologics.
- Explain the role of over-the-counter medications in acute management of dermatological conditions.
- Assess monitoring for signs of infection and the importance of appropriate use of antibiotics in conjunction with other therapies.
- Discuss non-pharmacological strategies in managing plaque psoriasis and atopic dermatitis, such as skincare routines, moisturizers, and phototherapy.
- Evaluate ongoing research and potential future treatments for both atopic dermatitis and plaque psoriasis.
- Address common barriers to treatment adherence and strategies to improve long-term management.
Outline
Atopic Dermatitis Current Clinical Treatment Guidelines- Topicals: Topical steroids, Calcinuerin Inhibitors, VTAMA, Opzelura
- Biologics (Dupixent, Adbry, Ebglyss)
- Jack Inhibitors: Cibinqo, Rinvoq
- TNF-Alpha Inhibitors
- IL-17 inhibitors
- IL-23 inhibitors
Over the Counter Medications
- Appropriate use of over-the-counter topical medications for dermatology problems
- Duration of OTC therapy before seeking a higher-level of care
- Wound Care
- Moisturizes and skincare routines (combination strategies)
- Brand new therapies in the pipeline
- Current literature with biologics
- Psoriasis
- Atopic Dermatitis
- Barriers
- Financial
- Cost effectiveness
- Prescription assistance programs
- Co-pay assistance cards
- Insurance
- Fact vs. myth over biologic
- Needle phobia
- Lab monitoring/follow up
- Uncertainty of treatment efficacy
- Financial
Target Audience
- NPs
- APRNs
- PAs
- PharmDs
- MDs
- DOs
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...



